Joanne Quan

Modulation Therapeutics (United States) — United States

Medicine · Health Sciences

13h-index3.4kcitations25works2.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cystic Fibrosis Research Advances(8), Neonatal Respiratory Health Research(7), Diabetes and associated disorders(4), Tracheal and airway disorders(4), Diabetes Management and Research(3)

Publications25 total

Pyrimidine Nucleos(t)ide Therapy in Patients With Thymidine Kinase 2 Deficiency
Neurology·2025· 4 citedOpen Access
OS-059 Volixibat for the treatment of cholestatic pruritus in primary biliary cholangitis: an adaptive, randomized, placebo-controlled phase 2b trial (VANTAGE): 28-week interim results
Journal of Hepatology·2025· 3 cited
784: VOLIXIBAT FOR THE TREATMENT OF CHOLESTATIC PRURITUS IN PRIMARY BILIARY CHOLANGITIS: AN ADAPTIVE, RANDOMIZED, PLACEBO-CONTROLLED PHASE 2B TRIAL (VANTAGE): INTERIM RESULTS
Gastroenterology·2025
Efficacy, safety, and tolerability of chenodeoxycholic acid (CDCA) in adult patients with cerebrotendinous xanthomatosis (RESTORE): A randomized withdrawal, double-blind, placebo-controlled, crossover phase-3 study
Genetics in Medicine·2025· 7 cited
P018: Safety and tolerability of chenodeoxycholic acid in pediatric patients with cerebrotendinous xanthomatosis (RESTORE): An open-label phase 3 study
Genetics in Medicine Open·2025Open Access
Collaborative model for diagnosis and treatment of very rare diseases: experience in Spain with thymidine kinase 2 deficiency
Orphanet Journal of Rare Diseases·2021· 8 citedOpen Access
EFFECTS OF LORCASERIN ON PREEXISTING VALVULOPATHY IN TWO PHASE 3 LORCASERIN TRIALS: A POOLED ANALYSIS
Journal of the American College of Cardiology·2014· 1 cited
Abstract 16016: The Effects of Lorcaserin on C-reactive Protein in Overweight and Obese Patients: Data From Two Phase 3 Trials
Circulation·2013
Plasmid-Encoded Proinsulin Preserves C-Peptide While Specifically Reducing Proinsulin-Specific CD8 <sup>+</sup> T Cells in Type 1 Diabetes
Science Translational Medicine·2013· 165 citedOpen Access
Recommendations for myasthenia gravis clinical trials
Muscle & Nerve·2012· 154 citedOpen Access
Evolution of MS lesions to black holes under DNA vaccine treatment
Journal of Neurology·2012· 17 cited
Early inflammation in the absence of overt infection in preterm neonates exposed to intensive care
Cytokine·2011· 38 citedOpen Access
T.114. Interim Results of a Phase I/II Clinical Trial of a DNA Plasmid Vaccine (BHT-3021) for Type 1 Diabetes
Clinical Immunology·2009· 1 cited
Computed Tomography Correlates with Pulmonary Exacerbations in Children with Cystic Fibrosis
American Journal of Respiratory and Critical Care Medicine·2005· 153 cited
High-resolution computed tomography in young patients with cystic fibrosis: Distribution of abnormalities and correlation with pulmonary function tests
The Journal of Pediatrics·2004· 351 cited
Bolus Inhalation of rhDNase with the AERx System in Subjects with Cystic Fibrosis
Journal of Aerosol Medicine·2003· 22 cited
Reply
The Journal of Pediatrics·2002Open Access
A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities
The Journal of Pediatrics·2001· 300 cited
Tobramycin Solution for Inhalation Reduces Sputum <i>Pseudomonas aeruginosa</i> Density in Bronchiectasis
American Journal of Respiratory and Critical Care Medicine·2000· 335 cited
Pacemaker wire infection caused by Bacillus licheniformis
Clinical Microbiology Newsletter·2000· 1 cited
page 1 of 2Next →

Frequent Co-authors

Will Garner(4), Pamela Vig(4), Hideki Garren(3), Lawrence Steinman(3), Bonnie W. Ramsey(2), Kelly Otto(2), A. Bruce Montgomery(2), C. Michael Bowman(2), Arnold L. Smith(2), Alan S. Brody(2), Jeffrey S. Klein(2), Paul L. Molina(2), Bart O. Roep(2), Nanette Solvason(2), Peter A. Gottlieb(2), Leonard C. Harrison(2), George S. Eisenbarth(2), R. S. B. King(2), Gary Cutter(2), Henk‐Jan Aanstoot(2)